Study of the kinetics of uremic toxins in the ICU patients with acute renal failure, in order to optimize the dialysis dose: patients with lactate acidosis. The sampling of blood and dialysate will be done during dialysis with different durations (4, 6 and 8...
Date First Received: September 12, 2008
Last Updated: April 20, 2009
Verified by: University Hospital, Ghent, April 2009
Clinical Trial Phase: N/A | Start Date: September 2008
Overall Status: Recruiting
Estimated Enrollment: 12
Brief Summary
Official Title: “Study of the Kinetics of Uremic Toxins in the ICU Patients With Acute Renal Failure, in Order to Optimize the Dialysis Dose: Patients With Lactate Acidosis”
Condition Keyword(s):
Study of the kinetics of uremic toxins in the ICU patients with acute renal failure, in order to optimize the dialysis dose: patients with lactate acidosis. The sampling of blood and dialysate will be done during dialysis with different durations (4, 6 and 8 h)
Study Type: Interventional
Study Design: Treatment, Randomized, Open Label, Active Control, Crossover Assignment, Efficacy Study
Study Primary Completion Date: December 2009
Intervention(s) in this Clinical Trial
- Procedure: Dialysis during 4 hours
- Blood and dialysate sampling
- Procedure: Dialysis during 6 hours
- Blood and dialysate sampling
- Procedure: Dialysis during 8 hours
- Blood and dialysate sampling
Arms, Groups and Cohorts in this Clinical Trial
- Experimental: 1
- Dialysis during 4 hours
- Experimental: 2
- Dialysis during 6 hours
- Experimental: 3
- Dialysis during 8 hours
Outcome Measures for this Clinical Trial
Primary Measures
- Toxin removal
- Time Frame: During dialysis
Safety Issue?: No
- Time Frame: During dialysis
Criteria for Participation in this Clinical Trial
Inclusion Criteria:
- Includes ICU patients with lactate acidosis with acute renal failure
Exclusion Criteria:
Gender Eligibility for this Clinical Trial: Both
Minimum Age for this Clinical Trial: 18 Years
Maximum Age for this Clinical Trial: N/A
Are Healthy Volunteers Accepted for this Clinical Trial?: No
Clinical Trial Sponsor Information
Lead Sponsor: University Hospital, Ghent
Overall Clinical Trial Officials and Contacts
Raymond Vanholder, MD, PhD Principal Investigator University Hospital, Ghent
Overall Contact: Sunny Eloot, PhD Sunny.eloot@ugent.be
Additional Information
Information obtained from ClinicalTrials.gov on July 02, 2009
Link to the current ClinicalTrials.gov record. http://clinicaltrials.gov/show/NCT00752453
Study ID Number: 2008/375
ClinicalTrials.gov Identifier: NCT00752453
Health Authority: Belgium: Institutional Review Board
Clinical Trials Authorship and Review
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.